248 related articles for article (PubMed ID: 28720517)
21. TRPM3_miR-204: a complex locus for eye development and disease.
Shiels A
Hum Genomics; 2020 Feb; 14(1):7. PubMed ID: 32070426
[TBL] [Abstract][Full Text] [Related]
22. CREB, AP-1, ternary complex factors and MAP kinases connect transient receptor potential melastatin-3 (TRPM3) channel stimulation with increased c-Fos expression.
Rubil S; Rössler OG; Thiel G
Br J Pharmacol; 2016 Jan; 173(2):305-18. PubMed ID: 26493679
[TBL] [Abstract][Full Text] [Related]
23. Activation of steroid-sensitive TRPM3 channels potentiates glutamatergic transmission at cerebellar Purkinje neurons from developing rats.
Zamudio-Bulcock PA; Everett J; Harteneck C; Valenzuela CF
J Neurochem; 2011 Nov; 119(3):474-85. PubMed ID: 21955047
[TBL] [Abstract][Full Text] [Related]
24. Structural requirements of steroidal agonists of transient receptor potential melastatin 3 (TRPM3) cation channels.
Drews A; Mohr F; Rizun O; Wagner TF; Dembla S; Rudolph S; Lambert S; Konrad M; Philipp SE; Behrendt M; Marchais-Oberwinkler S; Covey DF; Oberwinkler J
Br J Pharmacol; 2014 Feb; 171(4):1019-32. PubMed ID: 24251620
[TBL] [Abstract][Full Text] [Related]
25. Hyperforin activates gene transcription involving transient receptor potential C6 channels.
Thiel G; Rössler OG
Biochem Pharmacol; 2017 Apr; 129():96-107. PubMed ID: 28110963
[TBL] [Abstract][Full Text] [Related]
26. TRPM3 Channels Play Roles in Heat Hypersensitivity and Spontaneous Pain after Nerve Injury.
Su S; Yudin Y; Kim N; Tao YX; Rohacs T
J Neurosci; 2021 Mar; 41(11):2457-2474. PubMed ID: 33478988
[TBL] [Abstract][Full Text] [Related]
27. Regulation of the transient receptor potential channel TRPM3 by phosphoinositides.
Tóth BI; Konrad M; Ghosh D; Mohr F; Halaszovich CR; Leitner MG; Vriens J; Oberwinkler J; Voets T
J Gen Physiol; 2015 Jul; 146(1):51-63. PubMed ID: 26123194
[TBL] [Abstract][Full Text] [Related]
28. Expression and function of transient receptor potential melastatin 3 in the spinal afferent innervation of the mouse colon.
King JW; Bennett ASW; Wood HM; Baker CC; Alsaadi H; Topley M; Vanner SA; Reed DE; Lomax AE
Am J Physiol Gastrointest Liver Physiol; 2024 Feb; 326(2):G176-G186. PubMed ID: 38084411
[TBL] [Abstract][Full Text] [Related]
29. Disease-associated mutations in the human TRPM3 render the channel overactive via two distinct mechanisms.
Zhao S; Yudin Y; Rohacs T
Elife; 2020 Apr; 9():. PubMed ID: 32343227
[TBL] [Abstract][Full Text] [Related]
30. Stimulation-dependent gating of TRPM3 channel in planar lipid bilayers.
Uchida K; Demirkhanyan L; Asuthkar S; Cohen A; Tominaga M; Zakharian E
FASEB J; 2016 Mar; 30(3):1306-16. PubMed ID: 26655382
[TBL] [Abstract][Full Text] [Related]
31. The TRPP2-dependent channel of renal primary cilia also requires TRPM3.
Kleene SJ; Siroky BJ; Landero-Figueroa JA; Dixon BP; Pachciarz NW; Lu L; Kleene NK
PLoS One; 2019; 14(3):e0214053. PubMed ID: 30883612
[TBL] [Abstract][Full Text] [Related]
32. Primidone inhibits TRPM3 and attenuates thermal nociception in vivo.
Krügel U; Straub I; Beckmann H; Schaefer M
Pain; 2017 May; 158(5):856-867. PubMed ID: 28106668
[TBL] [Abstract][Full Text] [Related]
33. Functional expression and pharmacological modulation of TRPM3 in human sensory neurons.
Vangeel L; Benoit M; Miron Y; Miller PE; De Clercq K; Chaltin P; Verfaillie C; Vriens J; Voets T
Br J Pharmacol; 2020 Jun; 177(12):2683-2695. PubMed ID: 31985045
[TBL] [Abstract][Full Text] [Related]
34. Pregnenolone sulphate- and cholesterol-regulated TRPM3 channels coupled to vascular smooth muscle secretion and contraction.
Naylor J; Li J; Milligan CJ; Zeng F; Sukumar P; Hou B; Sedo A; Yuldasheva N; Majeed Y; Beri D; Jiang S; Seymour VA; McKeown L; Kumar B; Harteneck C; O'Regan D; Wheatcroft SB; Kearney MT; Jones C; Porter KE; Beech DJ
Circ Res; 2010 May; 106(9):1507-15. PubMed ID: 20360246
[TBL] [Abstract][Full Text] [Related]
35. The newest TRP channelopathy: Gain of function TRPM3 mutations cause epilepsy and intellectual disability.
Zhao S; Rohacs T
Channels (Austin); 2021 Dec; 15(1):386-397. PubMed ID: 33853504
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Transient Receptor Potential Melastatin 3 ion channels by G-protein βγ subunits.
Badheka D; Yudin Y; Borbiro I; Hartle CM; Yazici A; Mirshahi T; Rohacs T
Elife; 2017 Aug; 6():. PubMed ID: 28829742
[TBL] [Abstract][Full Text] [Related]
37. Transient Receptor Potential Melastatin 3 Is Functionally Expressed in Oligodendrocyte Precursor Cells and Is Upregulated in Ischemic Demyelinated Lesions.
Ohashi K; Shibasaki K; Nakazawa H; Kunimasa R; Nagayasu K; Shirakawa H; Kaneko S
Biol Pharm Bull; 2021; 44(2):181-187. PubMed ID: 33518671
[TBL] [Abstract][Full Text] [Related]
38. TRPM3.
Oberwinkler J; Philipp SE
Handb Exp Pharmacol; 2014; 222():427-59. PubMed ID: 24756716
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of transient receptor potential cation channel subfamily M member-3 in bladder afferents is involved in chronic pain in cyclophosphamide-induced cystitis.
Zhao M; Liu L; Chen Z; Ding N; Wen J; Liu J; Ge N; Zhang X
Pain; 2022 Nov; 163(11):2200-2212. PubMed ID: 35413036
[TBL] [Abstract][Full Text] [Related]
40. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
